As of 2026-03-13, the Intrinsic Value of Pliant Therapeutics Inc (PLRX) is -16.84 USD. This PLRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.41 USD, the upside of Pliant Therapeutics Inc is -1,294.31%.
Based on its market price of 1.41 USD and our intrinsic valuation, Pliant Therapeutics Inc (PLRX) is overvalued by 1,294.31%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.84 - -16.84 | -16.84 | -1,294.31% |
| P/E | (64.93) - (67.49) | (66.52) | -4817.5% |
| DDM - Stable | (37.99) - (141.22) | (89.60) | -6454.8% |
| DDM - Multi | (37.46) - (107.71) | (55.52) | -4037.6% |
| Market Cap (mil) | 86.64 |
| Beta | 1.56 |
| Outstanding shares (mil) | 61.45 |
| Enterprise Value (mil) | 23.35 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.18% |
| Cost of Debt | 5.00% |
| WACC | 6.96% |